Live Birth Rate of Frozen-Thawed Single Blastocyst Transfer After 6 or 7 Days of Progesterone Administration in Hormone Replacement Therapy Cycles: A Propensity Score-Matched Cohort Study
- PMID: 34456866
- PMCID: PMC8385316
- DOI: 10.3389/fendo.2021.706427
Live Birth Rate of Frozen-Thawed Single Blastocyst Transfer After 6 or 7 Days of Progesterone Administration in Hormone Replacement Therapy Cycles: A Propensity Score-Matched Cohort Study
Abstract
Background: Progesterone administration before transfer in hormone replacement treatment (HRT) is crucial to pregnancy outcomes in frozen-thawed blastocyst transfer (FET), but the optimal progesterone duration is inconsistent. The objective of this study was to investigate live birth rate (LBR) of different progesterone duration before blastocyst transfer in HRT-FET cycles.
Method: In this retrospective cohort study, patients underwent first HRT-FET (including suppression HRT) from January 2016 to December 2019 were included. Logit-transformed propensity score matching (PSM) was performed to assess covariates. The primary outcome was live birth rate after 28 weeks' gestation. Basing on different duration of progesterone before transfer, patients were classified into P6-protocol (blastocyst transfer performed on the sixth day), or P7-protocol (blastocyst transfer performed on the seventh day). Subgroup analyses were conducted as follows: age stratification (-35, 35-38, 38-), development days of blastocyst (D5 or D6), blastocyst quality (high-quality or poor-quality), and endometrial preparation protocols (HRT or suppression HRT).
Result: After case matching with propensity score methods, a total of 1,400 patients were included finally: 700 with P6-protocol and 700 with P7-protocol. Significantly higher live birth rate (38.43% versus 31.57%, respectively, P = 0.01) and clinical pregnant rate (50.43% versus 44.14%, respectively, P = 0.02) were observed in P6-protocol than those of P7-protocol. First-trimester abortion rates (18.13% versus 20.71%, P = 0.40) and ectopic pregnancy rates (2.27% versus 1.94%, P = 0.77) were similar between P6- and P7-groups. Preterm birth rate, low birth weight rate, newborn sex proportion, neonatal malformation rate were comparable between groups. Significantly higher LBRs were observed in patients with: age under 35, D5 blastocyst transfer, high-quality blastocyst transfer, and undergoing HRT cycles combined P6-protocol.
Conclusion: Frozen-thawed blastocyst transfer on the sixth day of progesterone administration in first HRT cycle is related to higher live birth rate compared with transfer on the seventh day, especially among patients aged under 35, D5 blastocyst and/or high-quality blastocyst transfer.
Keywords: blastocyst transfer; frozen-thawed embryo transfer; hormone replacement treatment; live birth rate; progesterone administration.
Copyright © 2021 Yang, Bu and Hu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Frozen-warmed blastocyst transfer after 6 or 7 days of progesterone administration: impact on live birth rate in hormone replacement therapy cycles.Fertil Steril. 2020 Jul;114(1):125-132. doi: 10.1016/j.fertnstert.2020.03.017. Epub 2020 Jun 16. Fertil Steril. 2020. PMID: 32553469
-
Live birth rate following frozen-thawed blastocyst transfer is higher with blastocysts expanded on Day 5 than on Day 6.Hum Reprod. 2018 Mar 1;33(3):390-398. doi: 10.1093/humrep/dey004. Hum Reprod. 2018. PMID: 29394365
-
Rectal progesterone administration secures a high ongoing pregnancy rate in a personalized Hormone Replacement Therapy Frozen Embryo Transfer (HRT-FET) protocol: a prospective interventional study.Hum Reprod. 2023 Nov 2;38(11):2221-2229. doi: 10.1093/humrep/dead185. Hum Reprod. 2023. PMID: 37759346 Free PMC article.
-
Successful pregnancy and live birth despite discontinuation of hormone replacement therapy at 3 weeks and 5 days of gestation following vitrified-warmed embryo transfer under a hormone replacement therapy cycle: a case report and literature review.BMC Pregnancy Childbirth. 2024 Dec 20;24(1):831. doi: 10.1186/s12884-024-07059-w. BMC Pregnancy Childbirth. 2024. PMID: 39707226 Free PMC article. Review.
-
Early pregnancy bleeding after assisted reproductive technology: a systematic review and secondary data analysis from 320 patients undergoing hormone replacement therapy frozen embryo transfer.Hum Reprod. 2023 Dec 4;38(12):2373-2381. doi: 10.1093/humrep/dead218. Hum Reprod. 2023. PMID: 37897214
Cited by
-
Comparison of clinical outcomes and perinatal outcomes between natural cycle and hormone replacement therapy of frozen-thawed embryo transfer in patients with regular menstruation: a propensity score-matched analysis.Front Endocrinol (Lausanne). 2024 Jul 18;15:1416841. doi: 10.3389/fendo.2024.1416841. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39092281 Free PMC article.
-
Association Between Pregnancy Outcomes and the Time of Progesterone Exposure of D6 Single-Blastocyst Transfer in Frozen-Thawed Cycles: A Retrospective Cohort Study.Int J Womens Health. 2024 Jun 10;16:1067-1077. doi: 10.2147/IJWH.S456706. eCollection 2024. Int J Womens Health. 2024. PMID: 38884053 Free PMC article.
-
Preparation of the endometrium for frozen embryo transfer: an update on clinical practices.Reprod Biol Endocrinol. 2023 Jun 8;21(1):52. doi: 10.1186/s12958-023-01106-5. Reprod Biol Endocrinol. 2023. PMID: 37291605 Free PMC article. Review.
-
Effects of different embryonic development days on clinical outcomes of freeze-thawed embryo transfer.Pak J Med Sci. 2025 Apr;41(4):1087-1091. doi: 10.12669/pjms.41.4.9634. Pak J Med Sci. 2025. PMID: 40290250 Free PMC article.
-
Association between duration of progesterone supplementation and clinical outcomes in artificial frozen-thawed embryo transfer cycles.Front Endocrinol (Lausanne). 2023 Jul 27;14:1193826. doi: 10.3389/fendo.2023.1193826. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37576967 Free PMC article. Clinical Trial.
References
-
- Peeraer K, Debrock S, Laenen A, De Loecker P, Spiessens C, De Neubourg D, et al. . The Impact of Legally Restricted Embryo Transfer and Reimbursement Policy on Cumulative Delivery Rate After Treatment With Assisted Reproduction Technology. Hum Reprod (2014) 29(2):267–75. 10.1093/humrep/det405 - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous